Insulet
PODD
NASDAQ
IPO2007
about PODD
Insulet is a company that develops and sells the Omnipod Insulin Therapy System, a tubeless insulin delivery system designed for people with diabetes to manage their condition without the need for traditional infusion pumps or multiple daily injections.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $296.08 | $297.11 | $293.51 | $20.69B | 273.61K |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| +$1.24 | 94.30 | 29.62 | 16.66% | 12.40% | 0% |